Global Coronary Stents Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

The Global Coronary Stents Market can be segmented based on product type into Drug-Eluting Stents (DES), Bare Metal Coronary Stents, and Bioabsorbable Stents. Drug-Eluting Stents are coated with medication to prevent the reoccurrence of blockages in the coronary artery post-procedure. These stents release drugs gradually to inhibit cell proliferation and reduce the risk of restenosis. Bare Metal Coronary Stents, on the other hand, are uncoated and primarily made of metal, typically stainless steel or cobalt-chromium alloy. They provide structural support to keep the artery open after angioplasty, but they do not release medication. Bioabsorbable Stents are designed to gradually dissolve over time, leaving behind a healed vessel without the presence of a permanent implant. These stents offer the advantage of reducing the risk of long-term complications associated with permanent implants, such as late stent thrombosis and vessel remodeling issues. Furthermore, the market can be segmented by end user into Hospitals and Ambulatory Surgical Centers (ASCs). Hospitals serve as the primary facilities for performing coronary interventions, including stent placements, due to their comprehensive medical infrastructure and specialized cardiac care units. They handle a significant volume of procedures and provide a wide range of healthcare services related to cardiovascular diseases. On the other hand, Ambulatory Surgical Centers offer outpatient procedures, including coronary stent placements, in a more convenient and cost-effective setting. ASCs are becoming increasingly popular for low-risk patients undergoing elective procedures, as they offer shorter wait times, reduced hospital stays, and a more comfortable environment for recovery. Additionally, ASCs are equipped with advanced technology and experienced medical staff to ensure the safe and efficient delivery of coronary interventions.

Global Coronary Stents Segment Analysis

In this report, the Global Coronary Stents Market has been segmented by Product Type, End User, and Geography.

Global Coronary Stents Market, Segmentation by Geography

In this report, the Global Coronary Stents Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Coronary Stents Market Share (%), by Geographical Region, 2024

North America dominated the coronary stents market and accounted for the largest revenue share of 32.6% in 2022 and is anticipated to witness the same trend over the foreseeable future. A sedentary lifestyle resulting in obesity and other cardiovascular diseases such as heart attack, stroke, ischemic heart diseases (IHD), etc., are primarily driving the market in North America. Technological advancements in coronary stent technologies, such as Drug-eluting stents and the use of biodegradable materials, have further augmented the market growth. The presence of mature market players such as Medtronic, Abbott & Boston Scientific is fueling market growth in this region.

The Asia Pacific market for coronary stents is expected to exhibit the fastest growth rate in terms of revenue generation. This market is driven by some additional variables of enhanced screening for CAD, economic growth, regulatory updates, and notable beneficial reimbursement in some the countries such as Australia and South Korea. Increased government investment in healthcare and conducting new initiatives to bring in devices at affordable prices in cost constraint markets such as India and China are influencing this market as well. For instance, in China, to address inflated pricing and other issues in the delivery of expensive medical supplies, the Chinese government launched a centralized procurement scheme for high-value medical consumables in January 2021. The government aims to use this initiative to skip the associated suppliers and buy the items straight from the manufacturers, lowering the inflated pricing. As a result, the cost of coronary stents has dropped dramatically in China. The average price of coronary stents has been reduced by 93% since 2019 to grab the national tender.

This report provides an in depth analysis of various factors that impact the dynamics of Global Coronary Stents Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers

• Increasing Prevalence of Cardiovascular Diseases
• Preference for Minimally Invasive Procedures

• Rising Healthcare Expenditure- As healthcare expenditure increases globally, particularly in developed countries, there is a corresponding rise in investment in advanced medical technologies and procedures, including coronary interventions such as stent placement. This increased investment translates into greater accessibility to coronary stents for patients with coronary artery disease (CAD), as healthcare facilities procure and stock these devices to meet the growing demand.
  Moreover, higher healthcare expenditure often correlates with improved healthcare infrastructure and resources, including cardiac catheterization labs and surgical facilities equipped for coronary interventions. These enhanced resources enable healthcare providers to offer a wider range of treatment options, including coronary stenting, to patients with CAD. Additionally, rising healthcare expenditure supports investments in research and development (R&D) for innovative stent technologies, driving continuous improvements in stent design, materials, and delivery systems. Furthermore, increased healthcare spending facilitates access to specialized cardiac care services, including diagnostic procedures, preoperative assessments, and postoperative follow-up, all of which are integral to the successful implementation of coronary stent procedures. This comprehensive approach to cardiac care contributes to improved patient outcomes and satisfaction.

Restraints

• High Cost of Treatment
• Availability of Alternative Treatments

• Limited Long-Term Efficacy Data- While coronary stents have demonstrated considerable success in improving blood flow to the heart and reducing symptoms of coronary artery disease (CAD) in the short term, there is a lack of comprehensive data on their performance and outcomes beyond a few years post-procedure. This limited long-term efficacy data creates uncertainty regarding the durability of stent patency, the risk of restenosis or thrombosis, and the need for additional interventions or revascularization procedures over time. Without robust evidence on the sustained benefits and potential complications associated with coronary stents, physicians may face challenges in making informed treatment decisions and counseling patients on the long-term risks and benefits.
  Similarly, patients may express concerns about the uncertainty surrounding the efficacy and safety of stent placement over the long term, impacting their confidence in undergoing the procedure. Addressing this restraint requires further research and longitudinal studies to evaluate the real-world performance of coronary stents over extended follow-up periods, providing clinicians and patients with reliable data to inform treatment decisions and optimize patient outcomes. Additionally, ongoing monitoring and surveillance programs are essential to track the long-term performance of coronary stents in clinical practice, identify potential complications or adverse events, and refine treatment strategies to enhance patient safety and efficacy. Overall, addressing the challenge of limited long-term efficacy data is crucial for advancing the field of interventional cardiology and optimizing the outcomes of coronary stent procedures in the management of CAD.

Opportunities

• Patient Education and Awareness

• Strategic Collaborations and Partnerships- In the highly dynamic and competitive landscape of the medical device industry, partnerships allow companies to leverage complementary strengths, resources, and expertise to accelerate product development, expand market reach, and address unmet needs more effectively. Collaborations between medical device manufacturers, research institutions, academic centers, and healthcare providers facilitate the exchange of knowledge, technology, and intellectual property, leading to the development of next-generation stent technologies with improved efficacy, safety, and patient outcomes. By pooling resources and sharing risks, companies can mitigate the high costs and uncertainties associated with research and development, regulatory approval, and market commercialization, enabling faster time-to-market for innovative stent solutions. Furthermore, strategic partnerships enable companies to access new markets, penetrate existing markets more effectively, and establish a stronger presence in emerging regions through distribution agreements, licensing arrangements, and joint ventures.
  Collaborations with healthcare providers also offer valuable insights into clinical needs, preferences, and outcomes, facilitating the design of patient-centric stent solutions tailored to specific clinical scenarios and patient populations. Overall, strategic collaborations and partnerships play a crucial role in driving innovation, fostering growth, and delivering value in the Coronary Stents Market, positioning companies for long-term success in a rapidly evolving healthcare landscape.

Key players in Global Coronary Stents Market include:

• Abbott
• Medtronic
• Boston Scientific Corporation
• Terumo Corporation
• B Braun Melsungen AG
• Biotronik
• Stentys SA
• MicroPort Scientific Corporation
• C. R. Bard, Inc.
• Cook Medical

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis